Chester County News and Community Website
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company, announced that it has entered into a loan and security agreement with Silicon Valley Bank (“SVB”) pursuant to …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, recently announced its financial results for the fourth quarter and full year 2019 and provided research and …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS) a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, announced it will report financial results for the fourth quarter and full year 2019, Tuesday, February 25th, …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, announced that management will present a company overview at the SVB Leerink 9th Annual Global Healthcare Conference …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, this week announced positive results from ATI-450-PKPD-101, a Single Ascending Dose and Multiple Ascending Dose (SAD/MAD) Phase …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a physician-led biopharmaceutical company focused on immuno-inflammatory diseases, this week announced the appointment of Vincent Milano to its board of directors, effective January 7, 2020.
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunology, announced …
Read More
WAYNE, PA — Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a dermatologist-led biopharmaceutical company committed to identifying, developing, and commercializing innovative therapies to address significant unmet needs in aesthetic and medical dermatology and immunology, …
Read More
MALVERN, PA — Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led biopharmaceutical company, announced that ESKATA™ is now available for purchase by dermatologists in the United States. ESKATA is the first and only …
Read More